Literature DB >> 24755273

DYNC1H1 mutation alters transport kinetics and ERK1/2-cFos signalling in a mouse model of distal spinal muscular atrophy.

Caroline A Garrett1, Muruj Barri1, Anna Kuta2, Violetta Soura1, Wenhan Deng1, Elizabeth M C Fisher2, Giampietro Schiavo3, Majid Hafezparast4.   

Abstract

Mutations in the gene encoding the heavy chain subunit (DYNC1H1) of cytoplasmic dynein cause spinal muscular atrophy with lower extremity predominance, Charcot-Marie-Tooth disease and intellectual disability. We used the legs at odd angles (Loa) (DYNC1H1(F580Y)) mouse model for spinal muscular atrophy with lower extremity predominance and a combination of live-cell imaging and biochemical assays to show that the velocity of dynein-dependent microtubule minus-end (towards the nucleus) movement of EGF and BDNF induced signalling endosomes is significantly reduced in Loa embryonic fibroblasts and motor neurons. At the same time, the number of the plus-end (towards the cell periphery) moving endosomes is increased in the mutant cells. As a result, the extracellular signal-regulated kinases (ERK) 1/2 activation and c-Fos expression are altered in both mutant cell types, but the motor neurons exhibit a strikingly abnormal ERK1/2 and c-Fos response to serum-starvation induced stress. These data highlight the cell-type specific ERK1/2 response as a possible contributory factor in the neuropathological nature of Dync1h1 mutations, despite generic aberrant kinetics in both cell types, providing an explanation for how mutations in the ubiquitously expressed DYNC1H1 cause neuron-specific disease.
© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ERK 1/2; Loa; cytoplasmic dynein; endosomes; motor neurons

Mesh:

Substances:

Year:  2014        PMID: 24755273     DOI: 10.1093/brain/awu097

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  9 in total

1.  Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons.

Authors:  Rahul Mohan; Andrew P Tosolini; Renée Morris
Journal:  J Vis Exp       Date:  2015-07-13       Impact factor: 1.355

2.  Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.

Authors:  Diana Wiesner; Jérome Sinniger; Alexandre Henriques; Stéphane Dieterlé; Hans-Peter Müller; Volker Rasche; Boris Ferger; Sylvie Dirrig-Grosch; Rana Soylu-Kucharz; Asa Petersén; Paul Walther; Birgit Linkus; Jan Kassubek; Philip C Wong; Albert C Ludolph; Luc Dupuis
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

Review 3.  A novel variant in DYNC1H1 could contribute to human amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Authors:  Alexios-Fotios A Mentis; Dimitrios Vlachakis; Eleni Papakonstantinou; Ioannis Zaganas; George P Patrinos; George P Chrousos; Efthimios Dardiotis
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

Review 4.  Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?

Authors:  Kurt J De Vos; Majid Hafezparast
Journal:  Neurobiol Dis       Date:  2017-02-22       Impact factor: 5.996

5.  DYNC1H1 mutations associated with neurological diseases compromise processivity of dynein-dynactin-cargo adaptor complexes.

Authors:  Ha Thi Hoang; Max A Schlager; Andrew P Carter; Simon L Bullock
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-14       Impact factor: 11.205

6.  An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy.

Authors:  Chung-Wei Yang; Chien-Lin Chen; Wei-Chun Chou; Ho-Chen Lin; Yuh-Jyh Jong; Li-Kai Tsai; Chun-Yu Chuang
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

7.  Identification of a de novo DYNC1H1 mutation via WES according to published guidelines.

Authors:  Dongxue Ding; Zhao Chen; Kai Li; Zhe Long; Wei Ye; Zhaoli Tang; Kun Xia; Rong Qiu; Beisha Tang; Hong Jiang
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

8.  A mathematical understanding of how cytoplasmic dynein walks on microtubules.

Authors:  L Trott; M Hafezparast; A Madzvamuse
Journal:  R Soc Open Sci       Date:  2018-08-08       Impact factor: 2.963

9.  Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma.

Authors:  Maoqing Lu; Sheng Qiu; Xianyao Jiang; Diguang Wen; Ronggui Zhang; Zuojin Liu
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.